B-HT 933 dihydrochloride

Pricing Availability   Qty
说明: Selective α2 agonist
别名: Azepexole
化学名: 6-Ethyl-5,6,7,8-tetrahydro-4H-oxazolo[4,5-d]azepin-2-amine dihydrochloride
纯度: ≥99% (HPLC)
说明书
引用文献 (1)
评论
文献 (2)

生物活性 for B-HT 933 dihydrochloride

B-HT 933 dihydrochloride is a selective α2-adrenoceptor agonist. Exhibits greater than 300-fold selectivity for the α2-adrenoceptor over the α1-adrenoceptor.

化合物库 for B-HT 933 dihydrochloride

B-HT 933 dihydrochloride is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for B-HT 933 dihydrochloride

分子量 254.16
公式 C9H15N3O.2HCl
储存 Desiccate at RT
纯度 ≥99% (HPLC)
CAS Number 36067-72-8
PubChem ID 169743
InChI Key HBLPYIOKPJVFQW-UHFFFAOYSA-N
Smiles CCN1CCC(OC(N)=N2)=C2CC1.Cl.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for B-HT 933 dihydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 25.42 100
DMSO 12.71 50

制备储备液 for B-HT 933 dihydrochloride

以下数据基于产品分子量 254.16。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 3.93 mL 19.67 mL 39.35 mL
5 mM 0.79 mL 3.93 mL 7.87 mL
10 mM 0.39 mL 1.97 mL 3.93 mL
50 mM 0.08 mL 0.39 mL 0.79 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for B-HT 933 dihydrochloride

分析证书/产品说明书
选择另一批次:

参考文献 for B-HT 933 dihydrochloride

参考文献是支持产品生物活性的出版物。

Bill et al (1989) The thermogenic actions of α2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic α2-adrenoceptor mechanism. Br.J.Pharmacol. 96 133 PMID: 2564288

Parkinson and Hughes (1995) The mechanism of action of α2-adrenoceptors in human isolated subcutaneous resistance arteries. Br.J.Pharmacol. 115 1463 PMID: 8564206

Kobinger and Pichler (1977) Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type". Naunyn-Schmied.Arch.Pharmacol. 300 39 PMID: 22821


If you know of a relevant reference for B-HT 933 dihydrochloride, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Adrenergic α2 Receptor Agonists

关键词: B-HT 933 dihydrochloride, B-HT 933 dihydrochloride supplier, B-HT933, dihydrochloride, azepexole, alpha2, α2, a2, adrenoceptors, agonists, selective, adrenergic, receptors, Azepexole, Adrenergic, Alpha-2, Receptors, 2758, Tocris Bioscience

1 篇 B-HT 933 dihydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。 B-HT 933 dihydrochloride 的部分引用包括:

Hamby et al (2012) Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. Toxins (Basel) 32 14489 PMID: 23077035


您是否知道使用了 Tocris B-HT 933 dihydrochloride 的优秀论文? 请告知我们.

B-HT 933 dihydrochloride 的评论

目前没有该产品的评论。 Be the first to review B-HT 933 dihydrochloride and earn rewards!

Have you used B-HT 933 dihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.